Ketoanalogues for Muscle Mass Loss in Nephrotic Syndrome
Status:
Recruiting
Trial end date:
2027-08-31
Target enrollment:
Participant gender:
Summary
The goal of this non-commercial clinical trial is to assess efficacy and safety of
ketoanalogues of essential amino acids in the prevention of protein-energy wasting in
nephrotic syndrome.
Phase:
Phase 3
Details
Lead Sponsor:
Military Institute of Medicine, Poland
Collaborators:
Medical University of Lodz Medical University of Warsaw